Related Experiment Videos
Reliability of antenatal testing: estriol levels versus nonstress testing
Obstetrics and Gynecology
|July 1, 1983
Summary
Nonstress testing (NST) is more reliable than plasma estriol levels for detecting fetal compromise in high-risk pregnancies. Abnormal NST results with lost fetal heart rate variability should guide antenatal surveillance.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Perinatal Diagnostics
Background:
- High-risk pregnancies require accurate antenatal surveillance to detect fetal compromise.
- Traditional methods include plasma estriol levels and fetal heart rate (FHR) monitoring.
- Evaluating the reliability of different antenatal tests is crucial for clinical decision-making.
Purpose of the Study:
- To compare the efficacy of nonstress testing (NST) with beat-to-beat FHR variability assessment against serial unconjugated plasma estriol determinations.
- To determine which antenatal test is more reliable in identifying fetal compromise in high-risk pregnancies during the third trimester.
Main Methods:
- Prospective follow-up of 334 high-risk pregnant patients in their third trimester.
- Antenatal fetal heart rate (FHR) evaluation including nonstress testing (NST) and beat-to-beat variability assessment.
- Serial determinations of unconjugated plasma estriol levels.
Main Results:
- Nonstress testing (NST) demonstrated higher reliability in assessing fetal compromise compared to estriol analysis.
- NST/beat-to-beat variability accurately identified fetal jeopardy in over 45.0% of at-risk fetuses.
- Abnormal estriol values accurately predicted jeopardy in only 22.8% of cases.
Conclusions:
- Nonstress testing (NST) with beat-to-beat FHR variability assessment is a more accurate predictor of fetal jeopardy than plasma estriol levels.
- Abnormal NST findings, particularly loss of beat-to-beat FHR variability, should take precedence in antenatal surveillance protocols for high-risk obstetric patients.
- These findings support the enhanced utility of FHR monitoring over biochemical markers for timely detection of fetal distress.